Showing 1691-1700 of 5758 results for "".
New OTC Topicals Target Hyperpigmentation, Melasma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-otc-topicals-target-hyperpigmentation-melasma/22081/There's a new and expanding menu of options to improve uneven tone, proving that OTCs can provide benefit for a vexing concern.New in My Practice Rx: Seysara (sarecycline)
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rx-seysara-sarecycline/20810/Approval for Evolus; Remembering Vic Narurkar, MD
https://practicaldermatology.com/topics/practice-management/dermwiretv-approval-for-evolus-remembering-vic-narurkar-md/19553/The FDA has approved Jeuveau, the lead product from Evolus, Inc. David Moatazedi, President and CEO of Evolus, and Michael Jafar, Chief Marketing Officer at Evolus, comment on market potential for the new product.Twenty-eight percent of physicians say the prior authorization process required by healBryhali, Xepi Launches; Epionce's New Facility
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bryhali-xepi-launches-epionce-s-new-facility/18213/Bryhali (halobetasol propionate) 0.01% Lotion from Ortho Dermatologics is now available for the topical treatment of plaque psoriasis in adults. Lawrence J. Green, MD a lead investigator on the Phase 3 studies speaks to DermWireTV. Botanical-based skincare company Epionce has a new 18,500 square fooBrightGuard Covers NYC, Galderma Uncovers Rosacea Burden, Dermira's Qbrexza Approved
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-brightguard-covers-nyc-galderma-uncovers-rosacea-burden-dermira-s-qbrexza-approved/18288/BrightGuard dispensers have now been installed at 53 public pools and 11 beaches in various locations throughout metropolitan New York. The impact of rosacea can be significant for affected patients. According to survey results released last month by Galderma, 86% of patients with rosacea modify theNew eRelevance Services, Cosmetic Bootcamp Updates, Leo & AID Partnership
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-new-erelevance-services-cosmetic-bootcamp-updates-leo-aid-partnership/18291/eRelevance has launched a suite of 4 services intended to support aesthetic practices in optimizing their marketing strategies to capture, convert, and retain patients. CEO Bob Fabbio discusses. Aesthetic education takes center stage at Cosmetic Boot Camp in Aspen. The meeting is open only to boardIndiana Gets SUNucated, Dr. Joel Cohen Honored, Rosacea Awareness
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-indiana-gets-sunucated-dr-joel-cohen-honored-rosacea-awareness/18317/Indiana is the first state in 2018 to give children broader access to sunscreen at school through the SUNucation Initiative. The Indiana Academy of Dermatology, with a grant from the American Society for Dermatologic Surgery Association, helped successfully pass the legislation. Joel L. Cohen, MD ofBest-in-Class At-Home Beauty Devices for Dermatologists
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/best-in-class-at-home-beauty-devices-for-dermatologists/20724/An experience-based assessment of a growing market segment.AAD SkinSerious Campaign, Meeting Highlights; Galderma Partners with Modernizing Medicine
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-aad-skinserious-campaign-meeting-highlights-galderma-partners-with-modernizing-medicine/18515/The American Academy of Dermatology's new SkinSerious campaign is raising awareness about skin disease and the specialty. The Skin Serious initiative kicked off at the AAD Annual Meeting in Orlando this month. New research presented at this year's meeting focused on skin disease prevention and treatValeant's Siliq Cleared, AmSpa Survey, New Skin Cancer Imaging
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-s-siliq-cleared-amspa-survey-new-skin-cancer-imaging/18527/The FDA has approved Valeant Pharmaceutical's Siliq (brodalumab) injection for subcutaneous use for patients with moderate-to-severe plaque psoriasis. The American Med Spa Association (AmSpa) has extended the deadline for its comprehensive survey of MedSpas nationwide. Multiphoton microscopy of mito